Sinclair Pharma PLC (LSE:SPH) - Share price - Overview

Stock Report

Sinclair Pharma PLC SPH

Last Price
GBX32.38

Day Change
0.63|1.97%

As of 24/02/2017
16:53:28 GMT | GBX
Minimum 15 Minutes Delay.

Last Close31.75p
Day Range31.50 - 32.50
Mkt Cap162.60Mil
52-Wk Range26.00 - 38.98
Yield %0.00
ISINGB0033856740
Volume187,006
P/E-30.69
P/S2.12
P/CF37.82

Share Price

Total Returns 24/02/2017

 Chg (%)  
More ...
Sinclair Pharma PLC3.60 
FTSE 100 TR GBP2.08
 
Financials
201320142015
More ...
Income Statement
Turnover55.3863.5675.89
Operating Profit-15.33-1.794.54
Net Profit-15.85-4.09-7.21
Reported EPS-3.70-0.90-1.50
Balance Sheet
Current Assets29.8554.6747.95
Non Current Assets126.17246.95237.47
Total Assets156.02302.72285.42
Current Liabilities24.0342.8846.75
Total Liabilities45.48184.80179.85
Total Equity110.54117.92105.57
Cash Flow
Operating Cash Flow2.58-4.369.98
Net Change in Cash1.0312.68-5.09
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-16.12-3.09--10.49---
2017-7.38-1.38--23.48---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/10/2016PurchaseMr. Jeff Thompson29.13150,00043,688.00
30/09/2016Transfer inMr. Chris Spooner0.001,101,3150.00
27/05/2016PurchaseMr. Jean-Charles Tschudin36.2597,00035,163.00
26/05/2016PurchaseMr. Jean-Charles Tschudin35.503,0231,073.00

Company Profile

Sinclair Pharma PLC is a specialty pharmaceutical company focused on Dermatology, in particular - Aesthetics, Wound care, and Skin care.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

752 of 1853 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(17/01/2017) "...management expects 2017 to be another year of strong revenue growth"

Next Event 21/03/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)-23.4814.3416.13
Div Yld (E)0.003.764.10
PEG (E)0.00-0.431.08
ROCE0.55202.62104.73
Op Mrgn-0.35-9.81-16.30
EPS Grwth0.0043.0235.18
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Grahame Cook
Chief Executive OfficerMr. Chris Spooner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.